Citation Impact
Citing Papers
Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
2009
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
2017
Head and neck squamous cell carcinoma
2020 Standout
Clinical update on head and neck cancer: molecular biology and ongoing challenges
2019
The versatility and adaptation of bacteria from the genus Stenotrophomonas
2009
Engineering precision nanoparticles for drug delivery
2020 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Lipid nanoparticles for mRNA delivery
2021 Standout
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
2018 StandoutNobel
IN SEARCH OF HEPATITIS C VIRUS RECEPTOR(S)
2001
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
Interaction between hepatitis C virus proteins and host cell factors
2002 StandoutNobel
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
HCV E2 core structures and mAbs: something is still missing
2014
Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes
2009
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus
2011 StandoutNobel
The long and winding road leading to the identification of the hepatitis C virus
2009 StandoutNobel
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
2008 StandoutNobel
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
2005 Standout
Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response
2020
Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells
2005 StandoutNobel
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
2010 StandoutNobel
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
2006
Hepatitis C Virus Entry
2007 StandoutNobel
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Photochemical internalization of tumor-targeted protein toxins
2011
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection
2004
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
2019 StandoutNobel
Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate
2012
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Hepatitis C Virus E2 Has Three Immunogenic Domains Containing Conformational Epitopes with Distinct Properties and Biological Functions
2004
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
CD81-Dependent Binding of Hepatitis C Virus E1E2 Heterodimers
2003
Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein
2012
Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona
2018
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Human Monoclonal Antibodies That React With the E2 Glycoprotein of Hepatitis C Virus and Possess Neutralizing Activity *
2005
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
The Hidden World within Plants: Ecological and Evolutionary Considerations for Defining Functioning of Microbial Endophytes
2015 Standout
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein
2005
Converting the personalized biomolecular corona of graphene oxide nanoflakes into a high-throughput diagnostic test for early cancer detection
2019
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
2018 Standout
Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus
2017 StandoutNobel
Identification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 Protein
2007
Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81
2000 StandoutNobel
In vitro selection of a neutralization-resistant hepatitis C virus escape mutant
2008
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies
2013
Masks for COVID‐19
2021
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
2008
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles
2019
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
2003 StandoutNobel
New photosensitizers for photodynamic therapy
2016 Standout
Human Monoclonal Antibodies That Inhibit Binding of Hepatitis C Virus E2 Protein to CD81 and Recognize Conserved Conformational Epitopes
2000
The role of apolipoprotein- and vitronectin-enriched protein corona on lipid nanoparticles forin vivotargeted delivery and transfection of oligonucleotides in murine tumor models
2019
Recognition of Native Hepatitis C Virus E1E2 Heterodimers by a Human Monoclonal Antibody
2002
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Neutralizing Antibody Response to Hepatitis C Virus
2011
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Diverse CD81 Proteins Support Hepatitis C Virus Infection
2006 StandoutNobel
Plant growth-promoting bacteria in the rhizo- and endosphere of plants: Their role, colonization, mechanisms involved and prospects for utilization
2009 Standout
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Characterization of an Immunodominant Antigenic Site on GB Virus C Glycoprotein E2 That Is Involved in Cell Binding
2006 StandoutNobel
Binding of the Hepatitis C Virus E2 Glycoprotein to CD81 Is Strain Specific and Is Modulated by a Complex Interplay between Hypervariable Regions 1 and 2
2003
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Works of Francesca Bugli being referenced
A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries
1998
Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant fab fragments
1998
Nonneutralizing Human Antibody Fragments against Hepatitis C Virus E2 Glycoprotein Modulate Neutralization of Binding Activity of Human Recombinant Fabs
2001
Biomimetic antimicrobial cloak by graphene-oxide agar hydrogel
2016
Analysis of heat-induced changes in protein expression of Stenotrophomonas maltophilia K279a reveals a role for GroEL in the host-temperature adaptation
2010
A vector for the expression of recombinant monoclonal Fab fragments in bacteria
1998
Curcumin-loaded graphene oxide flakes as an effective antibacterial system against methicillin-resistantStaphylococcus aureus
2018
Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells
2017
Production and Characterization of a Human Recombinant Monoclonal Fab Fragment Specific for Influenza A Viruses
2003
A novel expression vector for production of epitope-tagged recombinant Fab fragments in bacteria
2001
Bacteria Meet Graphene: Modulation of Graphene Oxide Nanosheet Interaction with Human Pathogens for Effective Antimicrobial Therapy
2017
Mapping B-Cell Epitopes of Hepatitis C Virus E2 Glycoprotein Using Human Monoclonal Antibodies from Phage Display Libraries
2001
Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis
2013